InvestorsHub Logo
Followers 0
Posts 46
Boards Moderated 0
Alias Born 01/24/2006

Re: None

Thursday, 05/11/2006 5:34:32 PM

Thursday, May 11, 2006 5:34:32 PM

Post# of 6489
My Patent Logic goes like this

Both IGF-1, and IGF-1 bound with IGFBP-3 are separate yet naturally occurring hormones in the body. As such a patent cannot be issued for a natural substance. Further the human body "manufactures" in separate processes both IGF-1 and IGF-1 bound with IGFBP-3. A patent can be issued for the process whereby these hormones are "manufactured" outside the body, but not the hormone itself. In the case of Insmed they have developed the science and process to make Iplex, a very difficult process, and should be awarded protection of their knowledge, science and methods.

I know this is simple, but as a layman, it is my understanding of Insmeds patent case.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News